AHSG and chronic kidney disease: Our results provide strong evidence that fetuin-A supplementation at the time of injury (e.g., ischemia-reperfusion injury in diverse organ systems) could be a promising therapeutic approach against hypoxia-induced mineral stress and fibrotic tissue remodeling, particularly in conditions associated with fetuin-A depletion, such as CKD or acute inflammation.